Patel Piyush R. 4
4 · Tyra Biosciences, Inc. · Filed Sep 8, 2022
Insider Transaction Report
Form 4
Patel Piyush R.
Chief Development Officer
Transactions
- Award
Stock Option (Right to Buy)
2022-09-06+30,924→ 30,924 totalExercise: $7.14Exp: 2032-09-05→ Common Stock (30,924 underlying) - Award
Common Stock
2022-03-15$8.53/sh+2,408$20,529→ 137,472 total - Award
Stock Option (Right to Buy)
2022-09-06+105,000→ 105,000 totalExercise: $7.14Exp: 2032-09-05→ Common Stock (105,000 underlying)
Footnotes (3)
- [F1]These shares were acquired under the Issuer's 2021 Employee Stock Purchase Plan.
- [F2]1/48th of the shares subject to the option vest monthly following September 6, 2022, the vesting commencement date, subject to the Reporting Person's continuous service to the Issuer through each vesting date.
- [F3]1/36th of the shares subject to the option vest monthly following September 6, 2022, the vesting commencement date, subject to the Reporting Person's continuous service to the Issuer through each vesting date.